- Beta blockers, or drugs used to slow the heart rate, such as acebutolol (Sectral®), atenolol (Tenormin®), bisoprolol (Zebeta®), and others
- Medications to treat irregular heartbeat, such as amiodarone (Cordarone®, Pacerone®), disopyramide (Norpace®), dofetilide (Tikosyn®) and others
- Other serotonin 5-HT3 antagonists, including Lotronex®, Anzemet®, Kytril®, and Aloxi® Some antibiotics, such as clarithromycin (Biaxin, in Prevpac®) and erythromycin (E.E.S., Erythrocin®)
- Some anti-seizure medications, such as phenytoin (Dilantin)
- Some antipsychotic medications, including thioridazine (Mellaril®), haloperidol (Haldol®), and mesoridazine (Serentil)
- Some drugs used to treat depression, including venlafaxine (Effexor®) and amitriptyline (Elavil®)
- The pain medicine tramadol (Ultram®, Ultracet®)
The antiemetic drug Zofran (ondansetron) produced by GlaxoSmithKline is FDA approved to prevent or treat nausea and vomiting caused by chemotherapy, radiation and surgery. Though the drug is not approved to treat morning sickness in pregnant women, many physicians prescribe Zofran for this use despite several studies finding it has the potential to cause birth defects.
Major Side Effects of Zofran
The most common adverse side effects of Zofran include headache, fatigue, anxiety, irritability, weakness, dry mouth, chills, drowsiness, insomnia, constipation, and diarrhea. As your body gets used to the medication, these symptoms may disappear, but if they persist, you should tell your doctor. If you or someone you know experiences any of the following more serious side effects of Zofran, call your doctor immediately or seek emergency medical treatment.
Common Zofran Side Effects
Much more severe conditions can result from taking Zofran, including serotonin syndrome and arrhythmia, both of which can result in death.
Researchers believe that the primary trigger of nausea and vomiting is rising levels of serotonin, a chemical produced naturally in the gastrointestinal tract and other areas of the body. Zofran helps prevent nausea and vomiting by blocking serotonin from reaching brain cells. When serotonin is prevented from reaching corresponding receptors in the brain, the chemical quickly accumulates. This buildup can lead to serotonin syndrome, which is essentially a type of poisoning that is life threatening.
Due to the physiological effects of blocking serotonin in this way, taking Zofran may lead to severe side effects and conditions (in addition to the ones listed above), including:
- Autonomic instability
- Labile blood pressure
- Neuromuscular problems
- Other mental status changes
These Zofran side effects are most frequently reported in patients who are taking other types of drugs that affect serotonin levels, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors, mirtazapine, fentanyl, lithium, tramadol, and intravenous methylene blue.
Zofran and Abnormal Heart Rhythms
In 2011, the FDA issued a safety warning that Zofran can affect the heart’s electrical cycle (known as the QT interval), which can impact the rhythm of the heart. Specifically, Zofran can increase the QT interval, leading to an abnormal heart condition known as torsades de pointes or “twisting of the points.” This is a life-threatening cardiac condition that causes a rapid heartbeat and may lead to sudden death by heart attack.
While this condition can occur with any form and dosage of Zofran, it is most closely linked with the intravenous (IV) 32 mg dosage. In 2012, the FDA issued a safety warning about the dangers of IV ondansetron, and as a result, several manufacturers took their versions of the drug off the market, including Baxter Healthcare, Hospira, Teva, Bedford Labs, and Claris.
For people with underlying heart conditions, such as long QT syndrome, taking Zofran may increase their already high risk for developing torsade de pointes. It is important to tell your doctor if you or your family members have this syndrome, or if you’ve ever had fainting spells due to an irregular heartbeat. Electrocardiogram (ECG) monitoring is recommended in patients with conditions such as congestive heart failure.
Zofran and Pregnancy
Although it has not been approved by the FDA for use by pregnant women in combating pregnancy-related nausea, Zofran has been prescribed by many doctors as an off-label treatment for morning sickness. Worldwide attention was brought to this off-label use of Zofran in 2012 and 2014 when Kate Middleton, the Duchess of Cambridge and wife of Prince William of England, was prescribed the drug for each of her two pregnancies. The risks related to pregnant women and fetuses are disputed and still largely unknown.
The FDA has stated that studies report “inconsistent outcomes,” and many have had problems with their methodologies that prevent the agency from making a determination about the drug’s safety. Research continues to link the medication with birth defects, prompting mothers to file Zofran lawsuits against the manufacturers.
A 2011 study by Boston University’s Slone Epidemiology Center and the Centers for Disease Control and Prevention found “possible risks” of Zofran, particularly for cleft palate. The researchers said they found statistical evidence that warranted further investigation.
Cardiac Septum Defect
In 2012, another study reviewed data from the Swedish Medical Birth Register and the Swedish Register of Prescribed Drugs on over 1,000 infants delivered by women who took ondansetron in early pregnancy between 1998 and 2012. After statistical analysis on the incidence of congenital malformations, researchers found a low but increased risk for a cardiac septum defect, but no increased risk for a major malformation.
Congenital Heart Defects
Two 2013 studies that used data from the Medical Birth Registry and National Patient Register in Denmark yielded conflicting results. Published in the New England Journal of Medicine, the first study analyzed data collected from 2004 to 2011, with an average fetus age exposed to Zofran at 10 weeks – past the window of time when malformations could develop. The study concluded there was no increased risk of adverse fetal outcomes. The second study look at data from 1997 to 2010, and found 58 women out of 1,248 that took ondansetron in the first trimester had a baby with a birth defect, representing a 30 percent increased risk.
A separate 2013 study examined birth records from 2002 to 2005 in Western Australia, and found no adverse outcomes but could not conclude that Zofran is safe to use in pregnancy. Researchers noted that although the study was too small to assess risks of individual birth defects, they did see a seven-fold increase in the risk for kidney malformations associated with the drug.
It is important to tell your doctor about all drugs you are taking, including over-the-counter medications, herbs, and supplements. Some drugs may affect the way Zofran works or may affect other medications you are taking. Drugs known to interact with Zofran, which may cause problems include:
Additionally, you should use caution while taking Zofran if you have certain health conditions. Let your doctor know if you have or ever had any of the following conditions:
- Inherited phenylketonuria, PKU
- Heart rhythm problems, including congenital long QT syndrome
- History of congestive heart failure
- Low magnesium or low potassium
- Liver disease